Financial News

05/03/2013 - 9:36am
April sales up 3.8% across Walgreens

Walgreens on Friday posted April sales of $6 billion, an increase of 3.8% as compared to the same month in fiscal 2012.

05/02/2013 - 10:57am
Energizer posts $7 million increase in profit in second quarter 2013

Energizer Holdings had sales of $1.095 billion in second quarter 2013, a 0.5% decrease from second quarter 2012, and $2.28 billion for the first six months of the fiscal year, which ended March 31, also a 0.5% decrease from the same period last year, the company said.

05/02/2013 - 10:40am
Investments in omnichannel, loyalty program highlighted at Sears Holdings shareholder meeting

Among the highlights of the first Sears Holdings shareholder meeting since Edward Lampert became chairman and CEO were details on the company's progress in combining its brick-and-mortar and online businesses.

05/02/2013 - 10:11am
Rite Aid comps decrease amid earlier Easter, new generics

Rite Aid's same-store sales decreased 4% in April compared with April 2012 due to an earlier Easter and introductions of new generic drugs, the retail pharmacy chain said.

05/02/2013 - 9:18am
Cardinal Health posts fewer sales but greater profits vs. Wall Street expectations

Cardinal Health reported fiscal year 2013 third-quarter revenue of $24.6 billion, a 8.9% decline as compared to the quarter a year ago.

05/01/2013 - 3:19pm
Bayer to acquire Conceptus for $1.1 billion

Bayer HealthCare will buy birth-control product maker Conceptus for $1.1 billion, the companies said.

05/01/2013 - 11:06am
Publix posts 6.1% gain in first-quarter sales

Publix posted first quarter sales of $7.5 billion, representing a 6.1% increase.

05/01/2013 - 11:01am
Actavis to acquire rights to Valeant drug

Drug maker Actavis has acquired rights to a treatment for an experimental bacterial vaginosis from Valeant Pharmaceuticals International for about $55 million, the drug makers said.

04/30/2013 - 11:18am
Family Dollar supply chain exec exits company

Family Dollar Stores on Monday announced Charles Gibson, EVP supply chain, will leave the company to pursue other interests effective April 30.

04/29/2013 - 2:09pm
Reports: Valeant, Actavis deal put on hold

A proposal by Canadian drug maker Valeant Pharmaceuticals International to purchase generic drug maker Actavis has fallen through, according to published reports.

© 2013 Drug Store News. All Rights Reserved.